IBDEI0VF ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15539,1,3,0)
 ;;=3^585.5
 ;;^UTILITY(U,$J,358.3,15539,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE V
 ;;^UTILITY(U,$J,358.3,15539,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,15540,0)
 ;;=585.6^^95^945^10
 ;;^UTILITY(U,$J,358.3,15540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15540,1,3,0)
 ;;=3^585.6
 ;;^UTILITY(U,$J,358.3,15540,1,4,0)
 ;;=4^ESRD
 ;;^UTILITY(U,$J,358.3,15540,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,15541,0)
 ;;=281.1^^95^946^2
 ;;^UTILITY(U,$J,358.3,15541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15541,1,3,0)
 ;;=3^281.1
 ;;^UTILITY(U,$J,358.3,15541,1,4,0)
 ;;=4^ANEMIA,B12 DEF
 ;;^UTILITY(U,$J,358.3,15541,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,15542,0)
 ;;=281.2^^95^946^3
 ;;^UTILITY(U,$J,358.3,15542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15542,1,3,0)
 ;;=3^281.2
 ;;^UTILITY(U,$J,358.3,15542,1,4,0)
 ;;=4^ANEMIA,FOLATE DEF
 ;;^UTILITY(U,$J,358.3,15542,2)
 ;;=^259686
 ;;^UTILITY(U,$J,358.3,15543,0)
 ;;=280.9^^95^946^4
 ;;^UTILITY(U,$J,358.3,15543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15543,1,3,0)
 ;;=3^280.9
 ;;^UTILITY(U,$J,358.3,15543,1,4,0)
 ;;=4^ANEMIA,IRON DEF
 ;;^UTILITY(U,$J,358.3,15543,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,15544,0)
 ;;=285.8^^95^946^1
 ;;^UTILITY(U,$J,358.3,15544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15544,1,3,0)
 ;;=3^285.8
 ;;^UTILITY(U,$J,358.3,15544,1,4,0)
 ;;=4^ANEMIA NEC
 ;;^UTILITY(U,$J,358.3,15544,2)
 ;;=^87876
 ;;^UTILITY(U,$J,358.3,15545,0)
 ;;=282.2^^95^946^5
 ;;^UTILITY(U,$J,358.3,15545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15545,1,3,0)
 ;;=3^282.2
 ;;^UTILITY(U,$J,358.3,15545,1,4,0)
 ;;=4^G6PD DEFICIENCY
 ;;^UTILITY(U,$J,358.3,15545,2)
 ;;=^7225
 ;;^UTILITY(U,$J,358.3,15546,0)
 ;;=V08.^^95^946^6
 ;;^UTILITY(U,$J,358.3,15546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15546,1,3,0)
 ;;=3^V08.
 ;;^UTILITY(U,$J,358.3,15546,1,4,0)
 ;;=4^HIV+ (ASYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,15546,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,15547,0)
 ;;=279.3^^95^946^7
 ;;^UTILITY(U,$J,358.3,15547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15547,1,3,0)
 ;;=3^279.3
 ;;^UTILITY(U,$J,358.3,15547,1,4,0)
 ;;=4^IMMUNITY DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,15547,2)
 ;;=^267969
 ;;^UTILITY(U,$J,358.3,15548,0)
 ;;=785.6^^95^946^8
 ;;^UTILITY(U,$J,358.3,15548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15548,1,3,0)
 ;;=3^785.6
 ;;^UTILITY(U,$J,358.3,15548,1,4,0)
 ;;=4^LYMPHADENOPATHY
 ;;^UTILITY(U,$J,358.3,15548,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,15549,0)
 ;;=075.^^95^946^9
 ;;^UTILITY(U,$J,358.3,15549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15549,1,3,0)
 ;;=3^075.
 ;;^UTILITY(U,$J,358.3,15549,1,4,0)
 ;;=4^MONONUCLEOSIS
 ;;^UTILITY(U,$J,358.3,15549,2)
 ;;=^62797
 ;;^UTILITY(U,$J,358.3,15550,0)
 ;;=238.4^^95^946^10
 ;;^UTILITY(U,$J,358.3,15550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15550,1,3,0)
 ;;=3^238.4
 ;;^UTILITY(U,$J,358.3,15550,1,4,0)
 ;;=4^POLYCYTHEMIA VERA
 ;;^UTILITY(U,$J,358.3,15550,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,15551,0)
 ;;=282.49^^95^946^11
 ;;^UTILITY(U,$J,358.3,15551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15551,1,3,0)
 ;;=3^282.49
 ;;^UTILITY(U,$J,358.3,15551,1,4,0)
 ;;=4^THALASSEMIA NEC
 ;;^UTILITY(U,$J,358.3,15551,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,15552,0)
 ;;=287.5^^95^946^12
 ;;^UTILITY(U,$J,358.3,15552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15552,1,3,0)
 ;;=3^287.5
 ;;^UTILITY(U,$J,358.3,15552,1,4,0)
 ;;=4^THROMBOCYTOPENIA NOS
 ;;^UTILITY(U,$J,358.3,15552,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,15553,0)
 ;;=289.9^^95^946^13
 ;;^UTILITY(U,$J,358.3,15553,1,0)
 ;;=^358.31IA^4^2
